Amen Clinics Home
Call Today!
(888) 564-2700

Monthly Archives: May 2008

ADD At Work

Here is a fascinating study from the World Health Organization on ADHD at work. 

Occup Environ Med. 2008 May 27. The Prevalence and effects of Adult ADHD on the performance of workers: Results from the WHO World Mental Health Survey Initiative. R. de Graaf and colleagues

 Netherlands Institute of Mental Health and Addiction, Netherlands.

OBJECTIVES: To estimate the prevalence and workplace consequences of adult attention-deficit/hyperactivity disorder (ADHD).

METHODS: Ann ADHD screen was administered to 18-44 year-old respondents in ten national surveys in the WHO World Mental Health (WMH) Survey Initiative (n = 7075 in paid or self employment; response rate 45.9-87.7% across countries). Blinded clinical reappraisal interviews were administered in the US to calibrate the screen.. Days out of role were measured in the WHO Disability Assessment Schedule (WHO-DAS). Questions were also asked about ADHD treatment.

RESULTS: An average of 3.5% of workers in the ten countries was estimated to meet DSM-IV criteria for adult ADHD (inter-quartile range: 1.3-4.9%). ADHD was more common among males than females and less common among professionals than other workers. ADHD was associated with a statistically significant 22.1 annual days of excess lost role performance compared to otherwise similar respondents without ADHD. No difference in the magnitude of this effect was found by occupation, education, age, gender, or partner status. This effect was most pronounced in Colombia, Italy, Lebanon, and the US. Although only a small minority of workers with ADHD ever received treatment for this condition, higher proportions were treated for comorbid mental-substance disorders.

CONCLUSIONS: ADHD is a relatively common condition among working people in the countries studied and is associated with high work impairment in these countries. This impairment, in conjunction with the low treatment rate and the availability of cost-effective therapies, suggests that ADHD would be a good candidate for targeted workplace screening and treatment programs. 

Wired Wrong

Wired Magazine writer-psychiatrist Daniel Carlat came to our clinic for a scan.  He was working on a negative article about how useless brain imaging is in clinical practice.  He took on fMRI, SPECT and qEEG.  He was not up front with his us about intent.  You can read the article online this month at wired.com\wired.  I wanted to post my response here and let you decide what you think.  Feel free to post your thoughts here and at wired.com.

I am saddened that Dr. Carlat could actually write at the end of his article that “My journey through the land of functional neuroimaging has helped me to understand how spectacularly meaningless these images are likely to be.” 

Maybe for someone like Danny who is not currently clinically depressed, the pictures have no meaning, but what about the patients with brain trauma, early dementia, toxic exposure, anoxia, or resistant psychiatric disorder that come through our offices that psychiatrists just missed because no one bothered to look at brain function. 

Or what about the boy who I saw two weeks ago who spent 18 months in a residential treatment facility and 30 days in a drug treatment program at a cost of more than $100,000 who had a tennis ball sized cyst in the left side of his brain, who had a normal neurological exam?  A neurosurgeon drained it at UCLA last week.  Dr. Carlat would have diagnosed him as a character disorder after the boy threatened to kill his mom and dad. I was hoping for a much more thoughtful article. 

I wonder why Dr. Carlat decided not to talk with many of the other people in my field who have been doing clinical brain imaging work for years, such as Ismael Mena, the grandfather of clinical imaging, or Mike Uszler at UCLA or Joe Wu at the University of California, Irvine or Jim Merikangas who used to be the president of the American Neuropsychiatric Association or Harold Bursztjan at Harvard who is director of the psychiatry and law program.  Dr. Bursztjan correctly says that scans do not give you the answer, they teach you to ask better questions. 

Psychiatrists make diagnoses today the same way they did in 1840 when Abraham Lincoln was depressed, through talking to patients and looking for symptom clusters.  Psychiatrists are the only medical specialists that never look at the organ they treat.  Isn’t that a scam…to make diagnoses of brain dysfunction without ever looking at the brain? 

No question we have a long way to go and a lot more research to do, but to continue as most psychiatrists currently practice is not only backwards it is downright hurtful to people.  

Dr. Rubin’s assessment of my work misses the mark completely.  I am not interested in what your brain looks like as part of a group of depressed patients.  I am looking at what your own brain specifically looks like.  I am looking at an N of 1, your brain.  Illnesses like depression will never have a singular finding on scans because they are not a singular disease.  There are many different types that need an individual approach, that is where scans help…what does your brain look like, so that I can target treatment specifically to your brain. 

Thomas Insel, Director of the National Institutes for Mental Health said in 2005 at the American Psychiatric Association that “Brain imaging in clinical practice is the next major advance in psychiatry…Trial and error diagnosis will move to an era where we understand the underlying biology of mental disorders….We are going to have to use neuroimaging to begin to identify the systems pathology that is distributed in each of these disorders and think of imaging as a biomarker for mental illnesses…The DSM-IV has 100%reliability and 0% validity. We need to develop biomarkers, including brain imaging, to develop the validity of these disorders….We need to develop treatments that go after the core pathology, understood by imaging…The end game is to get to an era of individualized care.

Dr. Insel believed in 2005 that brain imaging in clinical practice would be a reality in 5 years. I think that brain imaging in clinical practice is long overdue. You can try to kill yourself in virtually every major city in the world, and no one will look at your brain! 

One of the pieces of information that Dr. Carlat left out of his article is that he came to our clinic and refused to fill out our intake questionnaires.  He wanted me to act like a palm reader and tell him what the scans said without much clinical information.  That is not how we practice.  That is not how any reputable physician operates.  We want all of the information, clinical information and scan information, before we make a diagnosis and prescribe a treatment plan.  Yet having said that, I was right!  He admits that his scan did in fact fit his clinical presentation.  He says it was because I am a good doctor (thanks Danny).  I would say it is because I am a good doctor with more information.  Don’t you want your doctor to have as much information before he goes about changing your brain?   

Here are two responses that patients have posted on the Wired site.

From Lauralee:

I was referred to the Amen Clinic in Newport Beach, CA, by Dr. Earl Henslin for a SPECT scan 5 ½ years ago.  At the time, I had to leave my job as Operations Manager with a company that I had been with for 23 years.  I had no idea what was wrong with me other than I thought that I was losing my mind.  In addition, I could not eat which caused my weight to drop to a very unhealthy level.  I also became agoraphobic after having traveled the world.  I had reached a point where it was more peaceful to be asleep than awake.  I never thought that anything like this would ever happen to me. Thanks to Dr. Amen’s pioneering research and development of the SPECT scan, I learned that I was severely depressed which was a symptom completely on the other end of the spectrum for me as I was always happy (or so I thought).  I had anxiety that was off the chart for which I was using large doses of Xanax in an attempt to unsuccessfully control.  After the SPECT scan reading, the appropriate medications and dosages were prescribed along with psychotherapy.   I can say that there is no way psychotherapy in and of itself would have ever helped me.  SPECT scans and psychotherapy definitely go hand in hand.  It only makes sense that psychiatrists and therapists would use a tool to help them ‘see’ the brain and make appropriate recommendations for treatment just as physicians have a myriad of tools to help them with a diagnosis elsewhere in the body.  Are all tools used for medical diagnosis perfect?  No.  Are all methods of treatment perfect?  No.  Do we know everything that there is to know about the brain?  No.  Is the technology for this perfected?  No.  But, some information is better than none and SPECT scans do provide this.  As with any cutting edge technology, the means of understanding the workings of the brain will evolve and become perfected.  If we never took the chance of using new technology in the beginning, thousands of people would not be blessed with longer and healthier lives in so many arenas.  SPECT scans take out some of the ‘guess work’ made by psychiatrists who have no concrete medical evidence on which to write prescriptions.   I owe my life to Dr. Amen and Dr. Earl Henslin and cannot say whether I would be here if it were not for the two of them.  I am now a happier person and look forward to the day ahead.  My husband acknowledges how much happier I am and even says that I now have a great sense of humor.  In addition, along the way I discovered my true passion in life which is photography for which I have won awards (and I never won anything in my life!).   Thank you Dr. Amen and Dr. Henslin!!!

From Kirsten:

After reading your article about brain scans I found it necessary to comment from a consumers perspective. Two years ago I took my father to the Amen Clinic out of desperation. He had been diagnosed with early onset Alzheimer’s disease, severe clinical depression, and was living as a recluse in a single room. After a thorough assessment Dr. Amen explained that my father did not have Alzheimer’s disease and was on combination of medication that was essentially toxic. Today my father is working, volunteers at the local church and is once again living on his own and able to drive.Since then I have referred four friends to the Amen clinic. Three out four of those friends reported dramatic changes and improvement in the way they felt afterwards. One of those friends took her teenage son to the have a scan as a last resort after he was arrested and placed on probation for drugs. Upon seeing the effects that his drug use has had on his brain he decided he no longer wants to have a brain that looks like “swiss cheese” and has not done drugs since. Maybe a picture really is worth a thousand words.

Kirsten

Be Authentic

Be authentic.   

FRANKFURT, Germany, May 16 (UPI) — A German scientist has proved that people forced to smile and take on-the-job insults suffer more and longer-lasting stress that may harm their health.

Dieter Zapf of the Johann Wolfgang Goethe University in Frankfurt studied 4,000 volunteers working in a fake call center. Half were allowed to respond in kind to abuse on the other end of the line while the other half had to suck it up, The Telegraph reports.

He found that those able to answer back had a brief increase in heart rate. Those who could not had stress symptoms that lasted much longer.

“Every time a person is forced to repress his true feelings there are negative consequences,” Zapf said. “We are all able to rein in our emotions but it becomes difficult to do this over a protracted period.”

In an interview with the German healthcare magazine Apotheken Umschau, Zapf suggested that people who must keep smiling on the job should get regular breaks to let it out.

Fish Oil and Personality

Here is a fascinating study from the Journal of Psychiatric Research.  If your spouse or child is disagreeable, more fish or fish oil may increase the peace at home.

Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers.Conklin,-S-M; Harris,-J-I; Manuck,-S-B; Yao,-J-K; Hibbeln,-J-R; Muldoon,-M-FPsychiatry-Res. 2007 Jul 30; 152(1): 1-10 Low dietary intake of omega-3 polyunsaturated fatty acids has been linked to several features of psychiatric symptomatology, including depression, disorders of impulse control, and hostility. Preliminary intervention trials of omega-3 fatty acid supplementation for clinical depression and other disorders have reported benefit. However, few studies have investigated the relationships between these fatty acids and normative variability in mood, behavior and personality. Participants were 105 hypercholesterolemic, but otherwise healthy, non-smoking adults. Fasting serum alpha-linolenic (alpha-LNA), eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) were assayed with gas chromatography. Participants completed the Beck Depression Inventory (BDI), the NEO Five Factor Personality Inventory (NEO-FFI) and the Barratt Impulsiveness Scale (BIS). In multivariate analyses, higher levels of the long chain omega-3 PUFAs, EPA and DHA, were associated with significantly reduced odds of scoring >or=10 on the BDI. Similarly, DHA and EPA covaried inversely with NEO-Neuroticism scores, whereas DHA was positively associated with NEO-Agreeableness. On the BIS, DHA was inversely related to cognitive impulsivity and alpha-LNA was inversely related to motor and total impulsivity. These findings suggest that omega-3 fatty acid status is associated with variability in affect regulation, personality and impulse control. 

Another Study Says Your Diet Matters: Atkins for Epilepsy

From the NY Times today comes a report on a high protein, very low carbohydrate diet to treat epilepsy.   Your diet matters to the health of your brain.  Recently I mentioned an elimination diet that was highly effective in treating ADD children.  Could it be our diets are making our brains sick?  It is at least part of the puzzle.  Enjoy the article by Aliyah Baruchin. 

A formerly controversial high-fat diet has proved highly effective in reducing seizures in children whose epilepsy does not respond to medication, British researchers are reporting.

As the first randomized trial of the diet, the new study lends legitimacy to a treatment that has been used since the 1920s but has until recently been dismissed by many doctors as a marginal alternative therapy.

“This is the first time that we’ve really got Class 1 evidence that this diet works for treatment of epilepsy,” said Dr. J. Helen Cross, professor of pediatric neurology at University College London and Great Ormond Street Hospital. She is a principal investigator on the study, which will appear in the June issue of The Lancet Neurology.

Though its exact mechanism is uncertain, the diet appears to work by throwing the body into ketosis, forcing it to burn fat rather than sugar for energy. Breakfast on the diet might consist of bacon, eggs with cheese, and a cup of heavy cream diluted with water; some children drink oil to obtain the fats that they need. Every gram of food is weighed, and carbohydrates are almost entirely restricted. Breaking the diet with so much as a few cookies can cause seizures to flare up.

For the British trial, the researchers enrolled 145 children ages 2 to 16 who had never tried the diet, who were having at least seven seizures a week and who had failed to respond to at least two anticonvulsant drugs.

One group began the ketogenic diet immediately. The control group waited three months before starting it. In the first group, 38 percent of the children had seizure rates reduced by half, compared with 6 percent in the control group. Five children in the diet group had reductions exceeding 90 percent.

Perceptions of the diet have changed sharply in the last decade. In 1993, a Hollywood producer, Jim Abrahams, took his 1-year-old son, Charlie, to Dr. John M. Freeman at the Pediatric Epilepsy Center at Johns Hopkins, which was one of the few centers championing the diet. Within three days of starting the diet, Charlie’s incapacitating seizures, which had resisted multiple medications and surgery, stopped entirely.

With his wife, Nancy, Mr. Abrahams founded the Charlie Foundation to Help Cure Pediatric Epilepsy to promote education about the diet. He produced an instructional video for parents and a made-for-television movie, “First Do No Harm,” starring Meryl Streep as a mother who seeks out the diet for her child.

As a result of the Johns Hopkins work, research on the diet blossomed and it became a standard treatment at hospitals and epilepsy centers in the United States and abroad.

Dr. Shlomo Shinnar, director of the Comprehensive Epilepsy Management Center at the Montefiore Medical Center in the Bronx, called the new study “an important trial that lays to rest the issue of ‘Does it really work or not?’ ”

Although the diet has to be medically supervised, Dr. Shinnar said, it is a mistake to believe that it requires extensive hospital resources and a staff’s constant attention. “Here they don’t have this,” he said of the British trial. “This study makes it clear that this actually can be made to work in a community setting.”